Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
31.67B
Market cap31.67B
Price-Earnings ratio
24.97
Price-Earnings ratio24.97
Dividend yield
0.89%
Dividend yield0.89%
Average volume
2.16M
Average volume2.16M
High today
$113.09
High today$113.09
Low today
$111.77
Low today$111.77
Open price
$112.90
Open price$112.90
Volume
495.61K
Volume495.61K
52 Week high
$160.27
52 Week high$160.27
52 Week low
$107.07
52 Week low$107.07

Stock Snapshot

Agilent(A) stock is priced at $112.08, giving the company a market capitalization of 31.67B. It carries a P/E multiple of 24.97 and pays a dividend yield of 88.8%.

On 2026-05-15, Agilent(A) stock traded between a low of $111.77 and a high of $113.09. Shares are currently priced at $112.08, which is +0.3% above the low and -0.9% below the high.

The Agilent(A)'s current trading volume is 495.61K, compared to an average daily volume of 2.16M.

During the past year, Agilent(A) stock moved between $107.07 at its lowest and $160.27 at its peak.

During the past year, Agilent(A) stock moved between $107.07 at its lowest and $160.27 at its peak.

A News

Simply Wall St 2d
Agilent Technologies Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story

Agilent Technologies (A) has been active on several fronts recently, from new collaborations in biopharma analytics to the launch of its 16850 Series portable l...

Agilent Technologies Valuation Check As New Biopharma Collaborations And Logic Analyzers Expand Growth Story

Analyst ratings

81%

of 21 ratings
Buy
81%
Hold
19%
Sell
0%

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.